ArticleAntimicrobial agents and chemotherapy2020

Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.

Markus Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.